02 May 2003
Synthesis and characterization of potent and selective cell permeable inhibitors of poly(ADP-ribose) glycohydrolaseD. Coyle, H. Kim, E. Jacobson, M. Jacobson
Med Sci Monit 2003; 9(1): 17- :: ID: 15064
Adenosine diphosphate (hydroxymethyl)pyrrolidinediol (ADP-HPD) has been shown to be a potent and specific inhibitor of poly(ADP-ribose) glycohydrolase (PARG) . While ADP-HPD inhibits PARG in vitro with an IC50 of approximately 0.2 KM, it is not bioavailable to intact cells due to its highly polar nature. Thus, we have synthesized a number of derivatives of ADP-HPD and evaluated their potency as PARG inhibitors in vitro and their ability to inhibit PARG in cells. Previous studies have shown that substitutions at the 2 position of the adenine ring greatly reduces the potency of ADP-HPD, thus a number of lipophilic derivatives at positions 8 and N6 of the adenine ring were synthesized for evaluation. Modifications at N6 resulted in an unacceptable loss of potency. Modifications at position 8 showed that addition of very bulk groups resulted in greatly diminished potency but a number of lipophilic groups retained good potency. For example, 8-octylamino-ADP-HPD (OA-ADP-HPD) inhibits PARG in vitro with an IC50 of approximately 1.0 KM. The ability of OA-ADP-HPD to inhibit PARG in cells was examined demonstrated by increased ADP-ribose polymer accumulation in MCF-7 cells following genotoxic stress. The effects of inhibition of PARG on ADP-ribose polymer metabolism and biological responses to genotoxic stress will be reported. Cell permeable analogs of ADP-HPD should be useful pharmacological tools to study ADP-ribose polymer metabolism and they have the potential to be useful therapeutic agents.References: 1.Slama et al: J Med Chem, 1995; 38: 389-393
Keywords: Poly(ADP-ribose) glycohydrolase, PARG, PARG inhibitors
01 June 2023 : EditorialEditorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness
Med Sci Monit 2023; 29:e941209
08 Jun 2023 : Clinical ResearchRisk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...
Med Sci Monit In Press; DOI: 10.12659/MSM.940134
08 Jun 2023 : Clinical ResearchA Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...
Med Sci Monit In Press; DOI: 10.12659/MSM.940124
08 Jun 2023 : Clinical ResearchBurden of COVID-19 on Mental Health of Resident Doctors in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940208
08 Jun 2023 : Clinical ResearchRisk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...
Med Sci Monit In Press; DOI: 10.12659/MSM.940251
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952